COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 638: Articles 6371-6380  | Next

Activation of SARS-CoV-2 by trypsin-like proteases in the clinical specimens of patients with COVID-19
Igarashi, E., Shimada, T., Yazawa, S., Saga, Y., Itamochi, M., Inasaki, N., Morinaga, Y., Oishi, K., Tani, H.
10.1101/2022.09.27.509803 — Posted: 2022-09-28
Mutational spectra distinguish SARS-CoV-2 replication niches
Ruis, C., Peacock, T. P., Polo, L. M., Masone, D., Soledad Alvarez, M., Hinrichs, A. S., Turakhia, Y., Ye, C., McBroome, J., Corbett-Detig, R., Parkhill, J., Floto, R. A.
10.1101/2022.09.27.509649 — Posted: 2022-09-28
SARS-CoV-2 variants show temperature-dependent enhancedpolymerase activity in the upper respiratory tract and high transmissibility
Kim, S.-M., Kim, E.-H., Casel, M. A. B., Kim, Y.-i., Sun, R., Kwack, M.-J., Yoo, J.-S., Yoo, M.-A., Yoo, K.-M., Jang, S.-G., Rollon, R., Choi, J. H., Gil, J., Eun, K., Kim, H., Ensser, A., Hwang, J., Song, M.-S., Kim, M. H., Jung, J. U., Choi, Y. K.
10.1101/2022.09.27.509689 — Posted: 2022-09-27
Nuclear translocation of spike mRNA and protein is a novel pathogenic feature of SARS-CoV-2.
Sattar, S., Kabat, J., Jerome, K., Feldmann, F., Bailey, K., Mehedi, M.
10.1101/2022.09.27.509633 — Posted: 2022-09-27
Wild red deer (Cervus elaphus) do not play a role as vectors or reservoirs of SARS-CoV-2 in north-eastern Poland.
Krupinska, M., Borkowski, J., Goll, A., Nowicka, J., Baranowicz, K., Bourret, V., Strandin, T., Maki, S., Kant, R., Sironen, T., Grzybek, M.
10.1101/2022.09.27.509682 — Posted: 2022-09-27
Nation-wide mammography screening participation in Denmark during the COVID-19 pandemic: An observational study
Olesen, T. B., Jensen, H., Moller, H., Jensen, J. W., Andersen, B., Vejborg, I., Njor, S. H.
10.1101/2022.09.26.22280381 — Posted: 2022-09-27
Comparative adverse effects, perceptions and attitudes related to BNT162b2, mRNA1273, or JNJ-78436735 SARS-CoV-2 vaccines: A population-based longitudinal cohort
Buerzle, O. V., Menges, D., Maier, J. D., Schams, D., Puhan, M. A., Fehr, J., Ballouz, T., Frei, A.
10.1101/2022.09.27.22280403 — Posted: 2022-09-27
Impact of Differential Vaccine Effectiveness on COVID-19 Hospitalization Cases: Projections for 10 Developed Countries where Booster Vaccines were Recommended
Maschio, M., Fust, K., Lee, A., Van de Velde, N., Buck, P. O., Kohli, M.
10.1101/2022.09.26.22280377 — Posted: 2022-09-27
Markovian Structures in Modeling COVID-19
Cui, E. H.
10.1101/2022.09.23.22280294 — Posted: 2022-09-27
Association of IFNAR2 rs2236757 and OAS3 rs10735079 polymorphisms with susceptibility to COVID-19 infection and severity
Abdelhafez, M., Nasereddin, A., Abu Shamma, O., Abed, R., Sinnokrot, R., Marof, O., Heif, T., Erekat, Z., Al-Jawabreh, A., Ereqat, s.
10.1101/2022.09.27.22280425 — Posted: 2022-09-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).